HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING A REDUCED-INTENSITY CONDITIONING REGIMEN WHICH CONSIST OF RITUXIMAB AND MESENCYMAL STEM CELL CO-INFUSION IN CHILDREN: PRELIMINARY RESULTS